Most HHS workers were emailed an offer to leave their job for as much as $25,000 as part of President Trump’s government cuts ...

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP Clears the ...

Khalil, who received his master's degree from Columbia, served as a negotiator for students as they bargained to end a tent ...

Two Forestry Development Authority's agents, a Zone Warden, Selma Kolako, and a Ranger, Oliver Jelleh, are said to be in trouble for doing their work in the Grebo-Krahn National Partk, where they have ...

Q4 2024 Earnings Call Transcript March 6, 2025 Phathom Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0 ...

Drug firm Indoco Remedies Ltd on Monday (March 10) announced that its clinical research win AnaCipher, based in Hyderabad, ...

Researchers are working on a device that uses artificial intelligence to guide the delivery of pain management drugs for ...

Mineralys Therapeutics' lorundrostat shows promising Phase 3 results in treating resistant hypertension, with 9.1 mmHg blood ...

February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number ...

The deal marks a major step taken by an Indian player in the pharmaceutical industry to enhance their oncology portfolio and progress into the high-margins specialty pharma market.

At the recent CBER agency workshop on cell therapies and tissue-based products, a few surprising ideas discussed could have ...